Flutialfa M Cream is a dermatological formulation that combines Fluticasone Propionate 0.005% w/w, a potent corticosteroid used to reduce itching, redness, and inflammation, with Mupirocin 2% w/w, an antibiotic effective against gram-positive bacteria, including Staphylococcus aureus. This dual-action combination is beneficial for conditions where inflammation is associated with bacterial infection.
The cream is widely used for treating eczema, impetigo, dermatitis, psoriasis flare-ups, contact allergies, and infected skin lesions. Fluticasone helps control inflammation and irritation, while Mupirocin prevents bacterial growth, helping the skin heal faster and reducing the recurrence of infection.
Flutialfa M Cream belongs to the anti-inflammatory, anti-infective, and dermatology care segment, making it a frequently prescribed product among dermatologists across India.
For PCD pharma franchise partners, wholesalers, and exporters, Flutialfa M Cream offers strong business potential due to its high prescription demand and relevance in routine dermatology practice. The product is available for bulk orders, monopoly-based franchise distribution, third-party manufacturing, institutional supply, and export, ensuring strong market margins and consistent demand.